India Plan To Fund Pharma R&D Meets Consumer Objections
This article was originally published in PharmAsia News
Executive Summary
An effort by the Indian government to contribute funds to help encourage more pharmaceutical research and development in the country has encountered objections from public interest groups. The government plan would allow drugs developed as a result of the funds to be patented. The groups say it is not fair to allow drugs developed with public money to be granted patents, saying the grant of a monopoly on marketing the drugs would cause them to be more expensive to the general public. (Click here for more